![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/twitter.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/Logo_LinkedIn_round.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/youtube.png)
![](https://www.medicinesforeurope.com/wp-content/uploads/2016/03/flickr.png)
The new report on The Impact of Biosimilar Competition in […]
Read moreThe European pharmaceutical industry welcomes the 3rd workshop on access […]
Read moreOver 100 participants explored different ways and opportunities to ensure […]
Read moreWith 10 years of positive experience with biosimilar medicines, medical […]
Read moreKey authorities, eminent lawyers and industry leaders discussed today in […]
Read moreOn 9th March, IFPMA launched jointly with EFPIA and EBE […]
Read moreMedicines for Europe welcomes the fact that EFPIA (supported by […]
Read moreToday, the European Parliament voted on the report on ‘Options […]
Read moreEurope is the cradle of the manufacturing industry and has […]
Read moreMedicines for Europe welcomes the approval by the European Parliament […]
Read more